Your browser is no longer supported. Please, upgrade your browser.
PCRX [NASD]
Pacira BioSciences, Inc.
Index- P/E18.31 EPS (ttm)3.32 Insider Own0.40% Shs Outstand43.83M Perf Week-1.60%
Market Cap2.67B Forward P/E15.55 EPS next Y3.90 Insider Trans-68.65% Shs Float43.10M Perf Month-10.64%
Income147.70M PEG0.54 EPS next Q0.70 Inst Own- Short Float16.61% Perf Quarter-19.30%
Sales443.00M P/S6.03 EPS this Y43.40% Inst Trans0.41% Short Ratio16.68 Perf Half Y20.31%
Book/sh14.85 P/B4.09 EPS next Y29.01% ROA12.70% Target Price80.92 Perf Year37.38%
Cash/sh13.41 P/C4.53 EPS next 5Y33.85% ROE26.30% 52W Range39.35 - 80.00 Perf YTD1.47%
Dividend- P/FCF69.04 EPS past 5Y136.60% ROI15.10% 52W High-22.13% Beta1.10
Dividend %- Quick Ratio2.80 Sales past 5Y11.50% Gross Margin73.10% 52W Low58.32% ATR2.53
Employees624 Current Ratio3.10 Sales Q/Q12.60% Oper. Margin9.20% RSI (14)41.52 Volatility3.80% 3.97%
OptionableYes Debt/Eq0.72 EPS Q/Q18.30% Profit Margin33.30% Rel Volume1.00 Prev Close60.72
ShortableYes LT Debt/Eq0.49 EarningsMay 04 BMO Payout0.00% Avg Volume429.35K Price62.30
Recom2.10 SMA20-2.10% SMA50-7.65% SMA200-1.96% Volume254,785 Change2.60%
Apr-21-21Resumed JP Morgan Neutral $70
Apr-09-21Initiated Berenberg Buy $93
Apr-07-21Resumed RBC Capital Mkts Outperform $86
Feb-11-21Downgrade Northland Capital Outperform → Market Perform $72 → $75
Jan-21-21Downgrade SVB Leerink Outperform → Mkt Perform $75
Sep-21-20Upgrade Northland Capital Market Perform → Outperform $58 → $67
Jul-06-20Reiterated Needham Buy $52 → $64
May-27-20Initiated Guggenheim Neutral
Apr-07-20Initiated Northland Capital Outperform $50
Mar-20-20Upgrade SVB Leerink Mkt Perform → Outperform $44
Feb-24-20Reiterated H.C. Wainwright Buy $60 → $63
Jan-24-20Initiated SunTrust Buy
Jan-23-20Initiated SunTrust Buy
Nov-06-19Initiated BTIG Research Buy $56
Jun-11-19Initiated Barclays Overweight $52
May-06-19Upgrade Mizuho Underperform → Neutral $29 → $38
May-02-19Upgrade Stifel Sell → Hold $45
Feb-01-19Downgrade Mizuho Neutral → Underperform
Aug-06-18Downgrade BofA/Merrill Buy → Neutral
Apr-09-18Reiterated H.C. Wainwright Buy $45 → $48
May-12-21 08:00AM  
May-11-21 08:00AM  
May-05-21 08:11AM  
May-04-21 02:30PM  
09:15AM  
08:00AM  
06:45AM  
Apr-21-21 07:30AM  
Apr-20-21 07:30AM  
07:30AM  
Apr-14-21 04:00PM  
Apr-07-21 08:00AM  
Mar-30-21 05:46AM  
Mar-27-21 11:31AM  
Mar-23-21 09:36AM  
Mar-22-21 06:42PM  
Mar-17-21 01:10PM  
Mar-15-21 01:05PM  
Mar-09-21 08:00AM  
Mar-03-21 07:30AM  
Feb-26-21 08:58AM  
Feb-25-21 04:01PM  
08:00AM  
06:30AM  
Feb-23-21 02:49PM  
Feb-18-21 07:30AM  
Feb-14-21 01:32PM  
Feb-10-21 07:00AM  
Jan-29-21 03:32AM  
Jan-26-21 03:39PM  
08:00AM  
Jan-15-21 11:40AM  
Jan-12-21 12:48PM  
Jan-08-21 04:18PM  
Jan-07-21 04:10PM  
07:30AM  
Jan-06-21 07:30AM  
Dec-15-20 02:39AM  
Dec-09-20 04:40PM  
07:30AM  
Nov-24-20 07:30AM  
Nov-19-20 10:08AM  
Nov-18-20 07:30AM  
Nov-16-20 01:48PM  
Nov-13-20 10:40AM  
Nov-11-20 01:27PM  
08:00AM  
Nov-10-20 07:30AM  
Nov-09-20 12:42PM  
Oct-30-20 12:57PM  
03:01AM  
Oct-29-20 09:15AM  
08:00AM  
06:30AM  
Oct-22-20 12:33PM  
Oct-21-20 07:30AM  
06:25AM  
Oct-20-20 07:30AM  
Oct-19-20 11:30AM  
Oct-07-20 08:00AM  
Sep-21-20 11:56AM  
Sep-18-20 08:07AM  
Sep-16-20 02:55PM  
Sep-15-20 07:30AM  
Sep-11-20 07:30AM  
Sep-09-20 08:00AM  
Sep-05-20 11:31AM  
Aug-06-20 08:00AM  
Aug-05-20 04:05PM  
07:30AM  
Aug-04-20 07:30AM  
Jul-30-20 07:30AM  
Jul-28-20 05:03PM  
Jul-12-20 12:43PM  
Jul-07-20 07:51PM  
Jul-06-20 04:02PM  
04:01PM  
Jul-02-20 07:30AM  
Jun-29-20 09:00AM  
Jun-16-20 07:30AM  
Jun-10-20 04:36PM  
May-27-20 07:30AM  
May-13-20 07:30AM  
May-07-20 08:00AM  
May-04-20 07:30AM  
Apr-30-20 07:30AM  
Apr-23-20 08:59AM  
Apr-07-20 05:00PM  
Apr-06-20 08:00AM  
Mar-21-20 11:30AM  
Mar-17-20 09:53AM  
Mar-13-20 12:45PM  
11:40AM  
Mar-10-20 10:24AM  
Mar-09-20 07:30AM  
Mar-05-20 07:44AM  
Mar-04-20 09:22AM  
Feb-27-20 12:32AM  
Feb-26-20 12:45PM  
11:40AM  
Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for health care practitioners and their patients in the United States. The company develops products based on its proprietary DepoFoam product delivery technology that encapsulates drugs without altering their molecular structure. It offers EXPAREL, a bupivacaine liposome injectable suspension, administered at the time of surgery to control pain and reduce or eliminate the use of opioids for acute postsurgical pain; and iovera system, a non-opioid handheld cryoanalgesia device used to deliver controlled doses of cold temperature only to targeted nerves. The company was formerly known as Pacira Pharmaceuticals, Inc. and changed its name to Pacira BioSciences, Inc. in April 2019. Pacira BioSciences, Inc. was incorporated in 2006 and is headquartered in Parsippany, New Jersey.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Williams Kristen MarieChief Administrative OfficerApr 13Option Exercise40.2821,823878,94346,710Apr 15 08:35 PM
Williams Kristen MarieChief Administrative OfficerApr 13Sale66.9521,8231,461,06824,887Apr 15 08:35 PM
WINSTON ROYChief Clinical OfficerMar 31Option Exercise34.3813,750472,65648,535Apr 02 06:33 PM
WINSTON ROYChief Clinical OfficerMar 31Sale70.6122,2241,569,19526,311Apr 02 06:33 PM
Riker Lauren BullaroVice President, FinanceMar 17Option Exercise10.812,00021,62015,181Mar 17 08:03 PM
Riker Lauren BullaroVice President, FinanceMar 17Sale70.012,000140,02013,181Mar 17 08:03 PM
Riker Lauren BullaroVice President, FinanceMar 15Option Exercise10.811,52016,43114,701Mar 17 08:03 PM
Riker Lauren BullaroVice President, FinanceMar 15Sale73.281,520111,38613,181Mar 17 08:03 PM
Froimson MarkDirectorMar 15Sale72.2673453,0395,242Mar 17 08:01 PM
Wicki AndreasDirectorMar 15Sale73.6810,601781,082451,324Mar 16 09:12 PM
Wicki AndreasDirectorMar 12Sale73.1058,7544,294,917461,925Mar 16 09:12 PM
Wicki AndreasDirectorMar 11Sale72.7060,5744,403,730520,679Mar 11 09:37 PM
Wicki AndreasDirectorMar 10Sale71.7876,4805,489,734581,253Mar 11 09:37 PM
Wicki AndreasDirectorMar 09Sale70.9035,1372,491,213657,733Mar 11 09:37 PM
HASTINGS PAUL JDirectorMar 05Option Exercise13.983,00041,9409,116Mar 09 04:12 PM
HASTINGS PAUL JDirectorMar 05Sale65.883,000197,6406,116Mar 09 04:12 PM
LONGENECKER JOHN P PHDDirectorMar 01Option Exercise13.985,00069,90022,757Mar 03 04:25 PM
LONGENECKER JOHN P PHDDirectorMar 01Sale72.265,000361,30017,757Mar 03 04:25 PM
STACK DAVID MCEO and ChairmanFeb 03Option Exercise10.8121,250229,71297,311Feb 04 07:58 PM
STACK DAVID MCEO and ChairmanFeb 03Sale71.2121,2501,513,25976,061Feb 04 07:58 PM
STACK DAVID MCEO and ChairmanFeb 02Option Exercise10.8121,250229,71297,311Feb 04 07:58 PM
STACK DAVID MCEO and ChairmanFeb 02Sale69.4121,2501,474,87476,061Feb 04 07:58 PM
REINHARDT MAXPresidentJan 06Sale60.811106,68914,000Jan 08 04:39 PM
Brege LauraDirectorNov 16Option Exercise13.9812,000167,76019,921Nov 17 05:39 PM
Brege LauraDirectorNov 16Sale65.9512,000791,4007,921Nov 17 05:39 PM
REINHARDT MAXPresidentNov 13Option Exercise42.5425,0001,063,50039,000Nov 17 05:28 PM
Riker Lauren BullaroVice President, FinanceNov 13Option Exercise10.813,00032,43016,181Nov 17 05:37 PM
Riker Lauren BullaroVice President, FinanceNov 13Sale63.813,000191,43013,181Nov 17 05:37 PM
WINSTON ROYChief Clinical OfficerNov 13Sale62.005,000310,00034,785Nov 17 05:30 PM
REINHARDT MAXPresidentNov 13Sale63.3825,0001,584,39014,000Nov 17 05:28 PM
STACK DAVID MCEO and ChairmanOct 16Option Exercise10.8130,000324,300203,377Oct 16 04:26 PM
STACK DAVID MCEO and ChairmanOct 16Sale55.5630,0001,666,800173,377Oct 16 04:26 PM
STACK DAVID MCEO and ChairmanOct 15Option Exercise10.8130,000324,300203,377Oct 16 04:26 PM
STACK DAVID MCEO and ChairmanOct 15Sale55.0030,0001,650,000173,377Oct 16 04:26 PM
STACK DAVID MCEO and ChairmanOct 14Option Exercise10.8130,000324,300203,377Oct 16 04:26 PM
STACK DAVID MCEO and ChairmanOct 14Sale55.5330,0001,665,900173,377Oct 16 04:26 PM
PACE GARY WDirectorSep 25Option Exercise16.6770,0001,166,900129,949Sep 29 05:16 PM
Williams Kristen MarieChief Administrative OfficerSep 17Option Exercise39.1927,8711,092,26852,758Sep 17 07:13 PM
REINHARDT MAXPresidentSep 17Option Exercise42.5425,0001,063,50039,000Sep 21 06:23 PM
REINHARDT MAXPresidentSep 17Sale59.8125,4201,520,31814,000Sep 21 06:23 PM
Williams Kristen MarieChief Administrative OfficerSep 17Sale59.8227,8711,667,29024,887Sep 17 07:13 PM
Riker Lauren BullaroVice President, FinanceSep 16Option Exercise10.813,00032,43016,181Sep 17 07:10 PM
Williams Kristen MarieChief Administrative OfficerSep 16Option Exercise39.1927,8531,091,56052,740Sep 17 07:13 PM
Williams Kristen MarieChief Administrative OfficerSep 16Sale60.1427,8531,675,15024,887Sep 17 07:13 PM
Riker Lauren BullaroVice President, FinanceSep 16Sale60.343,000181,02013,181Sep 17 07:10 PM
Williams Kristen MarieChief Administrative OfficerSep 15Option Exercise39.1927,8531,091,56052,740Sep 17 07:13 PM
Williams Kristen MarieChief Administrative OfficerSep 15Sale59.3927,8531,654,05824,887Sep 17 07:13 PM
Wicki AndreasDirectorSep 09Sale62.022,216137,436692,970Sep 11 08:03 PM
STACK DAVID MCEO and ChairmanAug 17Sale61.9115,000928,619173,377Aug 19 05:44 PM
Wicki AndreasDirectorAug 13Sale61.4734,9042,145,549695,186Aug 13 08:58 PM
Wicki AndreasDirectorAug 12Sale60.82113,5006,903,070730,090Aug 13 08:58 PM
Riker Lauren BullaroVice President, FinanceAug 11Option Exercise10.348,18084,58120,813Aug 13 04:35 PM
Riker Lauren BullaroVice President, FinanceAug 11Sale60.508,180494,89013,181Aug 13 04:35 PM
Wicki AndreasDirectorAug 11Sale61.32106,7726,546,747843,590Aug 13 08:58 PM
LARANJEIRA CHARLES ANTHONYSVP, Technical OperationsAug 03Option Exercise44.102,500110,25022,750Aug 05 05:16 PM
LARANJEIRA CHARLES ANTHONYSVP, Technical OperationsAug 03Sale52.682,500131,70020,796Aug 05 05:16 PM
STACK DAVID MCEO and ChairmanJul 15Sale56.8812,000682,560188,377Jul 17 05:44 PM
LARANJEIRA CHARLES ANTHONYSVP, Technical OperationsJun 29Option Exercise42.0756,2502,366,58880,351Jul 01 09:17 PM
Riker Lauren BullaroVice President, FinanceJun 29Option Exercise10.346,00062,04018,633Jul 01 09:20 PM
Riker Lauren BullaroVice President, FinanceJun 29Sale49.476,000296,80012,633Jul 01 09:20 PM
LARANJEIRA CHARLES ANTHONYSVP, Technical OperationsJun 29Sale50.2760,1013,021,31420,250Jul 01 09:17 PM
STACK DAVID MCEO and ChairmanJun 08Sale48.1217,111823,402166,909Jun 08 09:09 PM
Williams Kristen MarieChief Administrative OfficerJun 05Sale48.615,904286,99310,887Jun 08 09:10 PM
Riker Lauren BullaroVice President, FinanceJun 05Sale48.371,75284,7447,833Jun 08 09:08 PM
Brege LauraDirectorJun 05Sale48.702,100102,2706,661Jun 08 09:04 PM
Williams Kristen MarieChief Administrative OfficerJun 04Sale46.332,402111,28716,791Jun 08 09:10 PM
STACK DAVID MCEO and ChairmanJun 04Sale46.3314,314663,182184,020Jun 08 09:09 PM
Riker Lauren BullaroVice President, FinanceJun 04Sale46.3387940,7259,585Jun 08 09:08 PM
McLoughlin DennisChief Commercial OfficerJun 04Sale46.331,44767,04114,898Jun 08 09:07 PM
Reinhart Charles A. IIIChief Financial OfficerJun 04Sale46.331,48968,98714,847Jun 08 09:07 PM
LARANJEIRA CHARLES ANTHONYSVP, Technical OperationsJun 04Sale46.3386339,98410,101Jun 08 09:06 PM
HASTINGS PAUL JDirectorJun 04Sale47.462,02596,1064,856Jun 08 09:05 PM
Riker Lauren BullaroVice President, FinanceMay 21Option Exercise10.342,00020,68012,464May 21 07:19 PM
Riker Lauren BullaroVice President, FinanceMay 21Sale45.262,00090,52010,464May 21 07:19 PM
Riker Lauren BullaroVice President, FinanceMay 19Option Exercise10.342,00020,68012,464May 21 07:19 PM
Riker Lauren BullaroVice President, FinanceMay 19Sale42.812,00085,62010,464May 21 07:19 PM